Organon (OGN) Interest Expenses (2021 - 2026)

Organon (OGN) posted quarterly Interest Expenses of $111.0 million for Q1 2026, down 10.48% year-over-year from $124.0 million in Q1 2025, and down 8.26% on a QoQ basis from $121.0 million in Q4 2025.

Organon (OGN) Interest Expenses (2021 - 2026) Analysis & Trends

Organon (OGN) has reported Interest Expenses for 6 consecutive years, with $111.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest Expenses fell 10.48% year-over-year to $111.0 million; the TTM figure through Mar 2026 stood at $491.0 million (down 4.29% YoY), while the FY2025 annual figure was $504.0 million, down 3.08% from the prior year.
  • Interest Expenses came in at $111.0 million for Q1 2026 at Organon, down from $121.0 million in the prior quarter.
  • The five-year high for Interest Expenses was $134.0 million in Q3 2023, with the low at $97.0 million in Q1 2022.
  • Average Interest Expenses over 5 years is $122.6 million, with a median of $128.0 million recorded in 2025.
  • Across the five-year window, Interest Expenses soared 58.06% in 2022 and retreated 10.48% in 2026, its largest moves.
  • Year by year, Interest Expenses stood at $119.0 million in 2022, then advanced by 8.4% to $129.0 million in 2023, then advanced by 2.33% to $132.0 million in 2024, then dropped by 8.33% to $121.0 million in 2025, then dropped by 8.26% to $111.0 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $111.0 million, $121.0 million, and $128.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 272.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -393.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 657.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 240.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -343.00 Mn
10 Organon 3.53 Bn 2.41 Bn 783.00 Mn 111.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 111.00 Mn
Mar 31, 2026 111.00 Mn
Dec 31, 2025 121.00 Mn
Dec 31, 2025 121.00 Mn
Sep 30, 2025 128.00 Mn
Sep 30, 2025 128.00 Mn
Jun 30, 2025 131.00 Mn
Jun 30, 2025 131.00 Mn
Mar 31, 2025 124.00 Mn
Mar 31, 2025 124.00 Mn
Dec 31, 2024 132.00 Mn
Dec 31, 2024 132.00 Mn
Sep 30, 2024 126.00 Mn
Sep 30, 2024 126.00 Mn
Jun 30, 2024 131.00 Mn
Jun 30, 2024 131.00 Mn
Mar 31, 2024 131.00 Mn
Mar 31, 2024 131.00 Mn
Dec 31, 2023 129.00 Mn
Dec 31, 2023 129.00 Mn